# A Phase I/II Study of Chondrogen Delivered by Intra-Articular Injection Following Meniscectomy

> **NCT00225095** · PHASE1,PHASE2 · COMPLETED · sponsor: **Mesoblast International Sàrl** · enrollment: 60 (actual)

## Conditions studied

- Recovery Following Partial Medial Meniscectomy

## Interventions

- **DRUG:** Mesenchymal Stem Cells
- **DRUG:** Hyaluronan

## Key facts

- **NCT ID:** NCT00225095
- **Lead sponsor:** Mesoblast International Sàrl
- **Sponsor class:** INDUSTRY
- **Phase:** PHASE1,PHASE2
- **Study type:** INTERVENTIONAL
- **Status:** COMPLETED
- **Start date:** 2005-09
- **Primary completion:** 2008-04
- **Final completion:** 2008-04
- **Target enrollment:** 60 (ACTUAL)
- **Last updated:** 2021-12-27

## Collaborators

- [object Object]
- [object Object]
- [object Object]
- [object Object]
- [object Object]
- [object Object]
- [object Object]
- [object Object]

## Primary source

ClinicalTrials.gov registry: https://clinicaltrials.gov/study/NCT00225095

## Citation

> US National Library of Medicine, ClinicalTrials.gov registration NCT00225095, "A Phase I/II Study of Chondrogen Delivered by Intra-Articular Injection Following Meniscectomy". Retrieved via AI Analytics 2026-06-02 from https://api.ai-analytics.org/clinical/NCT00225095. Licensed CC0.

---

*[Clinical trials dataset](/datasets/clinical-trials) · CC0 1.0*